Digital Biomanufacturing Market Growth, Industry Analysis And Segmentation Report To 2033

The Digital Biomanufacturing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Digital Biomanufacturing Market:
https://www.thebusinessresearchcompany.com/report/digital-biomanufacturing-global-market-report

According to The Business Research Company’s Digital Biomanufacturing Global Market Report 2024, The digital biomanufacturing market size has grown rapidly in recent years. It will grow from $18.87 billion in 2023 to $21.57 billion in 2024 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to increasing complexity of biopharmaceuticals, rise in personalized medicine, demand for cost-effective production, bioprocess optimization, quality control and regulatory compliance.

The digital biomanufacturing market size is expected to see rapid growth in the next few years. It will grow to $35.01 billion in 2028 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to blockchain for supply chain transparency, advanced process control (APC) systems, emphasis on sustainability, interconnected biomanufacturing ecosystems, biomanufacturing in emerging markets. Major trends in the forecast period include integration of artificial intelligence (AI), digital twins for bioprocessing, advancements in biotechnology, Industry 4.0 integration, real-time monitoring and control.

The growing demand for biologics is expected to propel the growth of the digital biomanufacturing market going forward. Biologicals are a vast class of pharmaceuticals that include vaccines, growth factors, immunological modulators, monoclonal antibodies, and drugs produced from human blood and plasma. Digital biomanufacturing is used to enhance biologics production by optimizing processes, quality control, lowering costs, and shortening production time, which helps producers to embrace data-driven methodologies and advanced technology to satisfy rising biologics demand more efficiently and sustainably. For instance, in January 2021, according to US Food and Drug Administration, a US-based federal agency of the Department of Health and human services, the Center for drug evaluation and Research (CDER), authorized 37 innovative pharmaceuticals in 2022, either as new molecular entities (NMEs) through new drug applications (NDAs) or as new therapeutic biological products through biologics license applications (BLAs). Further, according to the National Library of Medicine, a US-based center of biomedical informatics and computational biology, there were 14 biologics approvals and authorization of 36 small molecules in 2021. Therefore, the growing demand for biologics is driving the digital biomanufacturing market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample_request?id=10828&type=smp

The digital biomanufacturing market covered in this report is segmented –

1) By Type: Manufacturing Technologies, Analytical And Process Control Technologies, Software, Other Types
2) By Types of Biologic(s) Manufactured: Antibodies, Cell And Gene Therapies, Proteins, Vaccines, Other Types
3) By Technology: AI And IoMT Solutions, Process Analytical Technologies, Data Analytics Software, Predictive Analytics And Digital Twin Technologies, Other Technologies
4) By Application: BioProcess Optimization, Biomanufacturing Process Automation And Control, Other Applications
5) By End User: Biopharmaceutical Companies, Academic And Research Institutes

Major companies operating in the market are undergoing into strategic collaborations to sustain their position in the market. Strategic collaborations promote collaboration, innovation, and efficiency in the digital biomanufacturing market, fostering an environment conducive to growth and technological advancement. For instance, in January 2022, Scitara DLX, a UK-based global provider of cloud-based platforms, has joined partnered with BioPhorum, a UK-based global collaboration community in the biopharmaceutical sector. This partnership aims to drive scientific advancements and accelerate biopharmaceutical innovation. As a member of BioPhorum, Scitara will participate in presentations and members-only events to further the collective knowledge on the lab of the future. The collaboration is expected to provide scientists with new insights to drive faster decision-making and deliver data integrity. Scitara’s cloud-based technology, including the Scitara DLX, is designed to provide a standardized platform for communication and automated data exchange, ultimately contributing to the acceleration of biopharmaceutical innovation and scientific discoveries.

The digital biomanufacturing market report table of contents includes:

1. Executive Summary

2. Digital Biomanufacturing Market Characteristics

3. Digital Biomanufacturing Market Trends And Strategies

4. Digital Biomanufacturing Market – Macro Economic Scenario

….

32. Global Digital Biomanufacturing Market Competitive Benchmarking

33. Global Digital Biomanufacturing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Digital Biomanufacturing Market

35. Digital Biomanufacturing Market Future Outlook and Potential Analysis

The Business Research Company

Europe: +44 207 1930 708